GLP-1 Drugs: Lower Heart & Kidney Risk in Type 1 Diabetes
Beyond Diabetes: GLP-1s Poised to Redefine Cardiovascular & Renal Health Nearly 1.4 million Americans are living with Type 1 diabetes, and for decades, managing the disease has primarily focused on blood sugar control. But a recent wave of research, culminating in studies published in Nature and reported by News-Medical, suggests a far more expansive role … Read more